Post-COVID-19 Spondylodiscitis: A Case Study and Review of the Literature

Author:

Popovici George-Cosmin12,Georgescu Costinela-Valerica34,Arbune Anca-Adriana5,Vasile Mihaela-Camelia16,Olteanu Ionut7,Arbune Manuela68

Affiliation:

1. School for Doctoral Studies in Biomedical Sciences “Dunarea de Jos” University from Galati, 800008 Galati, Romania

2. Pneumophtiziology Hospital Galati, 800189 Galati, Romania

3. Pharmaceutical Sciences Department “Dunarea de Jos” University from Galati, 800008 Galati, Romania

4. Gynecology and Obstetrics Clinic Hospital Galati, 544886 Galati, Romania

5. Neurology Department Clinic Institute Fundeni Bucharest, 022328 Bucharest, Romania

6. Clinic Hospital for Infectious Diseases Galati, 800179 Galati, Romania

7. Emergency University Clinic Hospital Bucharest, 050474 Bucharest, Romania

8. Medical Clinic Department “Dunarea de Jos” University from Galati, 800008 Galati, Romania

Abstract

COVID-19 is currently a major health problem, leading to respiratory, cardiovascular and neurological complications, with additional morbidity and mortality. Spinal infections are rare, representing around 1% of all bone infections and comprising less than 2 per 10,000 of all hospitalizations in tertiary care centers. Spondylodiscitis is a complex disease, with challenging diagnosis and management. We report the case of a 45-year-old man, non-smoker hospitalized for severe COVID-19 disease with respiratory failure. Post-COVID-19, in the 8th week after discharge, he was diagnosed by magnetic resonance imaging with spondylodiscitis, but etiology was not confirmed by microbiological investigations. Antibiotics were used, considering the identification of MRSA from cultures of pleural fluid and nasal swab, but surgical intervention was not provided. Clinic, biologic and imagistic were improved, but rehabilitation and long term follow up are necessary. We concluded that spondylodiscitis with spinal abscess is a rare but severe complication post-COVID-19 disease, due to dysbalanced immune response related to the respiratory viral infection, endothelial lesions, hypercoagulation and bacterial superinfection.

Publisher

MDPI AG

Subject

General Medicine

Reference39 articles.

1. World Health Organization (2023, February 24). Clinical Management of COVID-19: Living Guideline, 15 September Geneva: World Health Organization; 2022 (WHO/2019-nCoV/Clinical/2022.2). Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2023.1.

2. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: A two-centre descriptive study;Carsana;Lancet Infect. Dis.,2020

3. New understanding of the damage of SARS-CoV-2 infection outside the respiratory system;Zhang;Biomed. Pharmacother.,2020

4. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy;Lodigiani;Thromb. Res.,2020

5. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up;Wang;J. Infect.,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3